Aflac Incorporated (NYSE: AFL) today announced that its Board of Directors has authorized the purchase of up to 100 million shares of its common stock. This authorization is in addition to the 30.9 million shares as of June 30, 2025, that remained under the November 8, 2022 authorization, bringing the total number of shares available for purchase to approximately 130.9 million. The company anticipates that the repurchase of shares will be conducted from time to time in open market or negotiated transactions, depending on market conditions. ABOUT AFLAC INCORPORATED Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for nearly seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products. In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force. The company takes pride in being there for its policyholders when they need us most, as well as being included in the World's Most Ethical Companies by Ethisphere for 19 consecutive years (2025) and Fortune's World's Most Admired Companies for 24 years (2025). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021 and has been included in the Dow Jones Sustainability North America Index (2024) for 11 years. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/español. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under "Sustainability." SUPPLEMENTAL INFORMATION The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. Aflac Incorporated (the Parent Company) and its subsidiaries (collectively with the Parent Company, the Company) desire to take advantage of these provisions. This document contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by Company officials in communications with the financial community and contained in documents filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as "expect," "anticipate," "believe," "goal," "objective," "may," "should," "estimate," "intends," "projects," "will," "assumes," "potential," "target," "outlook" or similar words as well as specific projections of future results, generally qualify as forward-looking. The Company undertakes no obligation to update such forward-looking statements. The Company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements: difficult conditions in global capital markets and the economy, including inflation defaults and credit downgrades of investments, global fluctuations in interest rates and exposure to significant interest rate risk, concentration of business in Japan, limited availability of acceptable yen-denominated investments, foreign currency fluctuations in the yen/dollar exchange rate, differing interpretations applied to investment valuations, significant valuation judgments in determination of expected credit losses recorded on the Company's investments, decreases in the Company's financial strength or debt ratings, decline in creditworthiness of other financial institutions, the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners, deviations in actual experience from pricing and reserving assumptions, ability to continue to develop and implement improvements in information technology systems and on successful execution of revenue growth and expense management initiatives, interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality, integrity or privacy of sensitive data residing on such systems, and uncertainty regarding the impact of the incident involving unauthorized access to the Company's network in June 2025, subsidiaries' ability to pay dividends to the Parent Company, inherent limitations to risk management policies and procedures, operational risks of third-party vendors, tax rates applicable to the Company may change, failure to comply with restrictions on policyholder privacy and information security, extensive regulation and changes in law or regulation by governmental authorities, competitive environment and ability to anticipate and respond to market trends, catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics, tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, major public health issues, terrorism or other acts of violence, and damage incidental to such events, ability to protect the Aflac brand and the Company's reputation, ability to effectively manage key executive succession, changes in accounting standards, level and outcome of litigation or regulatory inquiries, allegations or determinations of worker misclassification in the United States.

Aflac Incorporated Announces Increase in Shares Authorized for Repurchase

Aflac Incorporated has authorized the purchase of up to 100 million additional shares of its common stock, bringing the total available for repurchase to approximately 130.9 million shares. This includes the remaining 30.9 million shares from a prior authorization dated November 8, 2022. The repurchases will occur through open market or negotiated transactions based on market conditions. Aflac, a Fortune 500 company, is known for its supplemental health insurance in the U.S. and cancer and medical insurance in Japan. It has been recognized as a 'World's Most Ethical Company' for 19 consecutive years and a 'World's Most Admired Company' for 24 years. The company is also a signatory to the Principles for Responsible Investment and has been included in the Dow Jones Sustainability North America Index for 11 years.